NCT07021911Recruiting
Concomitant Radiotherapy and New Drugs in Metastatic Breast Cancer
Source: ClinicalTrials.gov · Last updated 15 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The primary objective of the study is to describe the tolerance profile of radiation treatments performed during systemic treatment with new drugs (molecular targeted therapies, immunotherapy, others).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 7 May 2025
- Start date
- 17 May 2023
- Primary completion date
- 17 May 2029
- Lead sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Diseases
- Metastatic breast cancer
- NCT number
- NCT07021911
What you commit to
- Study type: Observational
- Planned participants: 300
- From 17 May 2023 to the primary completion date, 17 May 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous radiation treatment on the same site
- Absolute contraindications to radiotherapy
Other
- Systemic treatment administered as part of a clinical trial
Who the study is looking for
- Patients suffering from stage IV breast cancer
- Ongoing systemic treatment including: molecular targeted therapy, conjugated antibodies, monoclonal antibodies, tyrosine kinase inhibitors, immunotherapy (immunocheckpoint inhibitors)
- Candidates for radiation treatment (both palliative and curative).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radiation Oncology Department Fondazione Policlinico Campus BioMedico Coordinator of this site? Confirm its status | Rome | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.